Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics
Wang, D.Y.; Sosman, J.A.; Johnson, D.B.
Oncology 29(12): 1005-1006
2015
ISSN/ISBN: 0890-9091 PMID: 26680225 Document Number: 685201
Document emailed within 1 workday
Related Documents
Kubo, M.; Morisaki, T.; Kuroki, H.; Tasaki, A.; Yamanaka, N.; Matsumoto, K.; Nakamura, K.; Onishi, H.; Baba, E.; Katano, M. 2003: Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer Anticancer Research 23(6a): 4443-4449Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Maruyama, S.; Yagita, A.; Sukegawa, Y. 2004: The significance of a combination of hepatic artery pump reservoir and new immunotherapy for cancer (NITC) in the treatment of colorectal liver metastasis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1764-1766
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
Holland, J.F.; Ohnuma, T. 1981: Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators Cancer Treatment Reports 65(Suppl 4): 123-130
Sarna, S.; Bhola, R.K. 1989: Adoptive immunotherapy of tumor in mice in combination with cyclophosphamide Archivum Immunologiae et Therapiae Experimentalis 37(5-6): 533-538
Fontecilla, N.M..; Khanna, T.; Bayan, C.-A.Y..; Antonov, N.A..; Geskin, L.J.. 2019: Bullous Pemphigoid Associated with a new Combination Checkpoint Inhibitor Immunotherapy Journal of Drugs in Dermatology: Jdd 18(1): 103-104
Kashimura, S.; Terashima, M.; Soeta, N.; Otani, S.; Hoshino, M.; Kanzaki, N.; Matsuyama, S.; Hoshino, Y.; Kogure, M.; Gotoh, M.; Ogata, T.; Ohto, H. 2004: Experimental study for a combination chemo-immunotherapy using dendritic cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1631-1633
Suvatte, V.; Mahasandana, C.; Tanphaichitr, V.S.; Tuchinda, S.; Vootiprux, V. 1981: Combination of chemotherapy, radiotherapy and immunotherapy for acute lymphoblastic leukemia in children Journal of the Medical Association of Thailand 64(4): 180-191
Turić, M.; Malenica, B.; Rogan-Grgas, J.; Milas, L. 1978: Combination of chemotherapy and immunotherapy in the treatment of carcinoma of the mammary gland in mice Lijecnicki Vjesnik 100(5): 289-294
Baral, E.; Nagy, E.; Kangas, L.; Berczi, I. 1997: Combination immunotherapy of the P815 murine mastocytoma with killer cells, IL-2 and anti-estrogens Anticancer Research 17(5a): 3653-3658
Campbell, M.J.; Esserman, L.; Levy, R. 1988: Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide Journal of Immunology 141(9): 3227-3233
Beltrán-Ortega, A.; Ramírez-Ugalde, M.T.; Mora-Tiscareño, A. 1978: Combination of surgery and immunotherapy in the treatment of melanoma. Experience of the National Institute of Oncology Gaceta Medica de Mexico 114(1): 29-36
DeVita, V.T. 1983: Advances in cancer therapeutics: chemotherapy Progress in Clinical and Biological Research 132a: 47-69
Felgner, P.L.; Zaugg, R.H.; Norman, J.A. 1995: Synthetic recombinant DNA delivery for cancer therapeutics Cancer Gene Therapy 2(1): 61-65
Wehrlin, N. 1983: Therapeutics: hormone therapy for breast cancer Revue de l'Infirmiere 33(11): 35-38
Hilgers, R.D.; Wyatt, S.W. 2007: Cancer of the cervix: the birth of a paradigm Journal of the Kentucky Medical Association 105(5): 203-204
Masucci, G.; Mellstedt, H. 1990: Biologic therapeutics as the fourth modality in cancer treatment Leukemia 4(2): 81-82
Shen, Y. 2008: Advances in the development of siRNA-based therapeutics for cancer Idrugs: the Investigational Drugs Journal 11(8): 572-578